Guangdong Taienkang Pharmaceutical Co. Ltd Total Assets

Latest as of June 2026: CN¥2.54 Billion CNY ≈ $371.06 Million USD

Guangdong Taienkang Pharmaceutical Co. Ltd total assets. Based on the latest financial reports, Guangdong Taienkang Pharmaceutical Co. Ltd (301263) holds total assets worth CN¥2.54 Billion CNY (≈ $371.06 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Guangdong Taienkang Pharmaceutical Co. L market cap and net worth for the company's overall valuation and market capitalisation.

Total Assets of Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2025)

Total assets of Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2025. This chart illustrates how Guangdong Taienkang Pharmaceutical Co. Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for Guangdong Taienkang Pharmaceutical Co. L for real-time trading data and today's change.

Guangdong Taienkang Pharmaceutical Co. Ltd - Asset Composition Analysis

Guangdong Taienkang Pharmaceutical Co. Ltd Total Assets Breakdown (December 2025)

Guangdong Taienkang Pharmaceutical Co. Ltd total assets breakdown as of December 2025. Guangdong Taienkang Pharmaceutical Co. Ltd's total assets of CN¥2.54 Billion consist of 46.9% current assets and 53.2% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	24.0%
Accounts Receivable	CN¥321.06 Million	13.3%
Inventory	CN¥98.81 Million	4.1%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥431.41 Million	17.9%
Goodwill	CN¥216.66 Million	9.0%

Asset Composition Trend (2019–2025)

This chart illustrates how Guangdong Taienkang Pharmaceutical Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Guangdong Taienkang Pharmaceutical Co. L working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Guangdong Taienkang Pharmaceutical Co. Ltd's current assets represent 46.9% of total assets in 2025, a decrease from 57.3% in 2019.
Cash Position: Cash and equivalents constituted 24.0% of total assets in 2025, up from 11.8% in 2019.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 25.0% of total assets, an increase from 11.0% in 2019.
Asset Diversification: The largest asset category is intangible assets at 17.9% of total assets.

Guangdong Taienkang Pharmaceutical Co. Ltd Competitors by Total Assets

Key competitors of Guangdong Taienkang Pharmaceutical Co. Ltd based on total assets are shown below.

Company	Country	Total Assets
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	China	CN¥9.54 Billion
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	China	CN¥6.44 Billion
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	China	CN¥1.54 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion
Bide Pharmatech Co. Ltd. A SHG:688073	China	CN¥2.54 Billion
Jianmin Pharmaceutical Group Co Ltd SHG:600976	China	CN¥4.69 Billion
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	China	CN¥2.26 Billion
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	China	CN¥25.73 Billion

Guangdong Taienkang Pharmaceutical Co. Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.68	2.25	7.43
Quick Ratio	1.52	2.02	7.05
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥446.91 Million	CN¥728.23 Million	CN¥1.45 Billion

Guangdong Taienkang Pharmaceutical Co. Ltd - Advanced Valuation Insights

This section examines the relationship between Guangdong Taienkang Pharmaceutical Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	6.11
Latest Market Cap to Assets Ratio	0.60
Asset Growth Rate (YoY)	4.6%
Total Assets	CN¥2.42 Billion
Market Capitalization	$1.44 Billion USD

Valuation Analysis

Below Book Valuation: The market values Guangdong Taienkang Pharmaceutical Co. Ltd's assets below their book value (0.60x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Guangdong Taienkang Pharmaceutical Co. Ltd's assets grew by 4.6% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2025)

The table below shows the annual total assets of Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥2.42 Billion ≈ $353.72 Million	+4.60%
2024-12-31	CN¥2.31 Billion ≈ $338.18 Million	+3.68%
2023-12-31	CN¥2.23 Billion ≈ $326.19 Million	+9.29%
2022-12-31	CN¥2.04 Billion ≈ $298.46 Million	+116.63%
2021-12-31	CN¥941.52 Million ≈ $137.77 Million	+12.79%
2020-12-31	CN¥834.75 Million ≈ $122.15 Million	+22.84%
2019-12-31	CN¥679.56 Million ≈ $99.44 Million	--

About Guangdong Taienkang Pharmaceutical Co. Ltd

SHE:301263 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.44 Billion

CN¥9.83 Billion CNY

Market Cap Rank

#7113 Global

#1439 in China

Share Price

CN¥19.25

Change (1 day)

-1.23%

52-Week Range

CN¥17.78 - CN¥34.45

All Time High

CN¥41.40